Revolution has set itself a mission to revolutionize treatment for patients with RAS addicted cancers. See why I upgrade RVMD ...

Oncosil Medical's investors have been promised a “catalyst rich” 2025 and 2026, including expected filings to the local TGA ...

For youth and adolescents battling cancer, researchers at the University of Calgary are finding ways to ensure they may still be able to have biological children later in life. In some cases where ...

NovoCure (Nasdaq: NVCR) announced good results today in its trial of a treatment for pancreatic cancer. The announcement ...

Citadel ended September with 91% fewer Palantir shares, despite the stock's eye-popping gains, after selling about 5.2 ...

BeiGene's Tevimbra receives EU approval for advanced ESCC and G/GEJ cancers, showing significant survival benefits in pivotal Phase 3 trials.

By slicing and dicing a dataset from 277 million patients at 1,591 hospitals, Epic publishes findings more quickly than ...

On her 59th birthday, Jacinta Frawley was diagnosed with ovarian cancer, yet still holding to her manners she made it her ...

Personally, when I was in treatment, I lived for the moments that felt "normal," when I could forget about cancer for a ...

NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact keiron.hughes@ ... preferences and values of their patients. The application of ...